Prevention of contrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography:: A randomized multicenter trial

被引：0
|
作者：
Gomes, VO
Caramori, P
Lasevitch, R
Brizolara, AA
Nery, P
Araújo, A
Hemesath, M
Brito, FS
机构：
[1] PUCRS, Hosp Sao Lucas, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Hosp Albert Einstein, Sao Paulo, Brazil
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2113
引用
收藏
页码：460 / 460
页数：1
相关论文
共 50 条
  • [31] High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy
    Marenzi, G.
    Trivedi, H.
    Daram, S.
    Szabo, A.
    Bartorelli, A. L.
    EUROPEAN HEART JOURNAL, 2009, 30 : 298 - 299
  • [32] High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy
    Trivedi, Hariprasad
    Daram, Sumanth
    Szabo, Aniko
    Bartorelli, Antonio L.
    Marenzi, Giancarlo
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (09): : 874.e9 - 874.e15
  • [33] Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
    Arabmomeni, Morteza
    Najafian, Jamshid
    Esfahani, Morteza Abdar
    Samadi, Mohsen
    Mirbagher, Leila
    ARYA ATHEROSCLEROSIS, 2015, 11 (01) : 43 - 49
  • [34] A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy following coronary angiography.
    Caputo, C
    Dokko, JH
    Durham, JH
    Pahlavan, M
    Keltz, J
    Dutka, P
    Marzo, K
    Zaharakis, T
    Fishbane, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) : A14 - A14
  • [35] Intravenous N-acetylcysteine for preventing contrast-induced nephropathy:: A randomised trial
    Carbonell, Nieves
    Blasco, Marisa
    Sanjuan, Rafael
    Perez-Sancho, Esther
    Sanchis, Juan
    Insa, Luis
    Bodi, Vicente
    Nunez, Julio
    Garcia-Ramon, Rafael
    Miguel, Alfonso
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 115 (01) : 57 - 62
  • [36] N-acetylcysteine and contrast-induced nephropathy in primary angioplasty
    Marenzi, Giancarlo
    Assanelli, Emilio
    Marana, Ivana
    Lauri, Gianfranco
    Campodonico, Jeness
    Grazi, Marco
    De Metrio, Monica
    Galli, Stefano
    Fabbiocchi, Franco
    Montorsi, Piero
    Veglia, Fabrizio
    Bartorelli, Antonio L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26): : 2773 - 2782
  • [37] n-Acetylcysteine for prevention of iodinated contrast-induced nephropathy in computed tomography angiography procedures in patients with chronic kidney disease
    Ye, Cheang Cheng
    Kumolosasi, Endang
    Wee, Chua Eng
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (03): : 181 - 189
  • [38] Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography
    MacNeill, BD
    Harding, SA
    Bazari, H
    Patton, KK
    Colon-Hernadez, P
    deJoseph, D
    Jang, IK
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 60 (04) : 458 - 461
  • [39] Use of intravenous dose of N-acetylcysteine for the prevention of contrast-induced nephropathy in high risk coronary patients. A randomised controlled trial
    Carbonell, N.
    Blasco, M. L.
    Manez, R. Sanjuan
    Sanchis, J.
    Bodi, V.
    Insa, L.
    EUROPEAN HEART JOURNAL, 2005, 26 : 425 - 425
  • [40] Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiac procedures
    Gowda, RM
    Shapiro, M
    Khan, IA
    Leibowitz, K
    Misra, D
    CHEST, 2004, 126 (04) : 710S - 710S
12345